FDA qui­et­ly chats with states on drug im­port plans — sig­nal­ing Biden is­n't ready to dis­pense with Trump's idea

The FDA last week qui­et­ly met for the first time with lead­ers from a hand­ful of states to dis­cuss their pend­ing and con­tro­ver­sial plans to im­port cheap­er drugs from Cana­da.

The push for such im­ports comes as Cana­di­an drug prices con­tin­ue to hov­er at a frac­tion of the prices seen across their south­ern bor­der.

An FDA spokesper­son con­firmed to End­points News that the meet­ing on March 31 was the first op­por­tu­ni­ty for FDA and HHS to meet with states that have tak­en sig­nif­i­cant ac­tion to­ward de­vel­op­ing an im­por­ta­tion pro­gram pro­pos­al, which cur­rent­ly in­cludes Flori­da, Col­orado, Maine, New Mex­i­co and Ver­mont.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER